CNR1 and liver cancer: It is well known that CBD is a multi-target molecule, and in addition to CB1 and CB2 receptors, it interacts with approximately 65 molecular targets [164] where it can behave as an activator or inhibitor, including a variety of ion channels involved in liver cancer.